ID   PODXL_CANLF             Reviewed;         571 AA.
AC   Q52S86;
DT   15-JUN-2010, integrated into UniProtKB/Swiss-Prot.
DT   24-MAY-2005, sequence version 1.
DT   02-DEC-2020, entry version 69.
DE   RecName: Full=Podocalyxin;
DE   AltName: Full=Gp135;
DE   AltName: Full=Podocalyxin-like protein 1;
DE            Short=PC;
DE            Short=PC-like protein 1;
DE            Short=PCLP-1;
DE            Short=cPCLP1;
DE   Flags: Precursor;
GN   Name=PODXL; Synonyms=PCLP, PCLP1;
OS   Canis lupus familiaris (Dog) (Canis familiaris).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Carnivora; Caniformia; Canidae; Canis.
OX   NCBI_TaxID=9615;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 398-406; 448-466 AND
RP   525-538, FUNCTION, SUBCELLULAR LOCATION, GLYCOSYLATION AT ASN-199; ASN-373
RP   AND ASN-383, MUTAGENESIS OF ASN-123; ASN-199; ASN-373 AND ASN-383, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=15814834; DOI=10.1681/asn.2004121145;
RA   Cheng H.Y., Lin Y.Y., Yu C.Y., Chen J.Y., Shen K.F., Lin W.L., Liao H.K.,
RA   Chen Y.J., Liu C.H., Pang V.F., Jou T.S.;
RT   "Molecular identification of canine podocalyxin-like protein 1 as a renal
RT   tubulogenic regulator.";
RL   J. Am. Soc. Nephrol. 16:1612-1622(2005).
RN   [2]
RP   FUNCTION, INTERACTION WITH SLC9A3R2, AND SUBCELLULAR LOCATION.
RX   PubMed=15642748; DOI=10.1083/jcb.200407072;
RA   Meder D., Shevchenko A., Simons K., Fuellekrug J.;
RT   "Gp135/podocalyxin and NHERF-2 participate in the formation of a preapical
RT   domain during polarization of MDCK cells.";
RL   J. Cell Biol. 168:303-313(2005).
RN   [3]
RP   SUBUNIT, INTERACTION WITH SLC9A3R1, GLYCOSYLATION AT ASN-199; ASN-373 AND
RP   ASN-383, AND MUTAGENESIS OF ASN-199; ASN-373 AND ASN-383.
RX   PubMed=17332505; DOI=10.1091/mbc.e06-07-0629;
RA   Yu C.Y., Chen J.Y., Lin Y.Y., Shen K.F., Lin W.L., Chien C.L.,
RA   ter Beest M.B., Jou T.S.;
RT   "A bipartite signal regulates the faithful delivery of apical domain marker
RT   podocalyxin/Gp135.";
RL   Mol. Biol. Cell 18:1710-1722(2007).
CC   -!- FUNCTION: Involved in the regulation of both adhesion and cell
CC       morphology and cancer progression. Functions as an anti-adhesive
CC       molecule that maintains an open filtration pathway between neighboring
CC       foot processes in the podocyte by charge repulsion. Acts as a pro-
CC       adhesive molecule, enhancing the adherence of cells to immobilized
CC       ligands, increasing the rate of migration and cell-cell contacts in an
CC       integrin-dependent manner. Induces the formation of apical actin-
CC       dependent microvilli. Involved in the formation of a preapical plasma
CC       membrane subdomain to set up initial epithelial polarization and the
CC       apical lumen formation during renal tubulogenesis. Plays a role in
CC       cancer development and aggressiveness by inducing cell migration and
CC       invasion through its interaction with the actin-binding protein EZR.
CC       Affects EZR-dependent signaling events, leading to increased activities
CC       of the MAPK and PI3K pathways in cancer cells.
CC       {ECO:0000269|PubMed:15642748, ECO:0000269|PubMed:15814834}.
CC   -!- SUBUNIT: Found in a complex with EZR, PODXL and SLC9A3R2. Associates
CC       with the actin cytoskeleton through complex formation with EZR and
CC       SLC9A3R2. Interacts (via the C-terminal PDZ-binding motif DTHL) with
CC       SLC9A3R1 (via the PDZ domains); interaction is not detected in
CC       glomerular epithelium cells. Interacts (via the C-terminal PDZ-binding
CC       motif DTHL) with SLC9A3R2 (via the PDZ 1 domain); interaction is
CC       detected in glomerular epithelium cells. Interacts with EZR (By
CC       similarity). Monomer; when associated with the membrane raft. Oligomer;
CC       when integrated in the apical membrane. Interacts with SLC9A3R2.
CC       Interacts (via the C-terminal PDZ-binding motif DTHL) with SLC9A3R1
CC       (via the PDZ domains); the interaction take place early in the
CC       secretory pathway and is necessary for its apical membrane sorting.
CC       {ECO:0000250, ECO:0000269|PubMed:15642748,
CC       ECO:0000269|PubMed:17332505}.
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane. Membrane raft. Cell
CC       projection, lamellipodium {ECO:0000250}. Cell projection, filopodium
CC       {ECO:0000250}. Cell projection, ruffle {ECO:0000250}. Cell projection,
CC       microvillus {ECO:0000250}. Membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}. Note=Forms granular, punctuated
CC       pattern, forming patches, preferentially adopting a polar distribution,
CC       located on the migrating poles of the cell or forming clusters along
CC       the terminal ends of filipodia establishing contact with the
CC       endothelial cells. Colocalizes with the submembrane actin of
CC       lamellipodia, particularly associated with ruffles. Colocalizes with
CC       vinculin at protrusions of cells. Colocalizes with ITGB1. Colocalizes
CC       with actin filaments, ezrin and SLC9A3R1 in a punctate pattern at the
CC       apical cell surface where microvilli form. Colocalizes with EZR and
CC       SLC9A3R2 at the apical cell membrane of glomerular epithelium cells (By
CC       similarity). In single attached epithelial cells is restricted to a
CC       preapical pole on the free plasma membrane whereas other apical and
CC       basolateral proteins are not yet polarized. Colocalizes with SLC9A3R2
CC       at the apical plasma membrane during epithelial polarization.
CC       Colocalizes with SLC9A3R1 at the trans-Golgi network (transiently) and
CC       at the apical plasma membrane. Its association with the membrane raft
CC       is transient. Colocalizes with PARD3, PRKCI, EXOC5, OCLN, RAB11A and
CC       RAB8A in apical membrane initiation sites (AMIS) during the generation
CC       of apical surface and luminogenesis (By similarity). {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in glomerular and tubular epithelial
CC       cells and peritubular capillaries of the kidney (at protein level).
CC       Expressed in heart, lung, renal cortex and medulla, kidney and muscle.
CC       {ECO:0000269|PubMed:15814834}.
CC   -!- DOMAIN: The large highly anionic extracellular domain allows to
CC       maintain open filtration pathways between neighboring podocyte foot
CC       processes. The cytoplasmic C-terminus PDZ-binding motif (DTHL) is
CC       essential for interaction with SLC9A3R1 and for targeting SLC9A3R1 to
CC       the apical cell membrane. The extracellular domain is necessary for
CC       microvillus formation (By similarity). Both the O-glycan-rich domain of
CC       the extracellular domain and the C-terminus PDZ-binding motif (DTHL) in
CC       the cytoplasmic tail harbor an apical sorting signal. The cytoplasmic
CC       domain is necessary for the apical membrane targeting and renal
CC       tubulogenesis. {ECO:0000250}.
CC   -!- PTM: N- and O-linked glycosylated. Sialoglycoprotein.
CC       {ECO:0000269|PubMed:15814834, ECO:0000269|PubMed:17332505}.
CC   -!- SIMILARITY: Belongs to the podocalyxin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY970669; AAX93749.1; -; mRNA.
DR   RefSeq; NP_001018645.1; NM_001020809.1.
DR   SMR; Q52S86; -.
DR   STRING; 9612.ENSCAFP00000041563; -.
DR   iPTMnet; Q52S86; -.
DR   PaxDb; Q52S86; -.
DR   GeneID; 482252; -.
DR   KEGG; cfa:482252; -.
DR   CTD; 5420; -.
DR   eggNOG; ENOG502S2JU; Eukaryota.
DR   InParanoid; Q52S86; -.
DR   OrthoDB; 1404598at2759; -.
DR   Proteomes; UP000002254; Unplaced.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0030175; C:filopodium; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0030027; C:lamellipodium; ISS:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; IEA:UniProtKB-SubCell.
DR   GO; GO:0031528; C:microvillus membrane; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0001726; C:ruffle; ISS:UniProtKB.
DR   GO; GO:0036057; C:slit diaphragm; ISS:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0016477; P:cell migration; ISS:UniProtKB.
DR   GO; GO:0072175; P:epithelial tube formation; IDA:UniProtKB.
DR   GO; GO:0072015; P:glomerular visceral epithelial cell development; ISS:UniProtKB.
DR   GO; GO:0007162; P:negative regulation of cell adhesion; ISS:UniProtKB.
DR   GO; GO:0022408; P:negative regulation of cell-cell adhesion; ISS:UniProtKB.
DR   GO; GO:0030335; P:positive regulation of cell migration; ISS:UniProtKB.
DR   GO; GO:0033634; P:positive regulation of cell-cell adhesion mediated by integrin; ISS:UniProtKB.
DR   GO; GO:0032534; P:regulation of microvillus assembly; ISS:UniProtKB.
DR   InterPro; IPR013836; CD34/Podocalyxin.
DR   InterPro; IPR017403; PODXL.
DR   PANTHER; PTHR12067; PTHR12067; 1.
DR   Pfam; PF06365; CD34_antigen; 1.
DR   PIRSF; PIRSF038143; Podocalyxin-like_p1; 1.
PE   1: Evidence at protein level;
KW   Cell adhesion; Cell membrane; Cell projection; Direct protein sequencing;
KW   Glycoprotein; Membrane; Phosphoprotein; Reference proteome; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL          1..22
FT                   /evidence="ECO:0000255"
FT   CHAIN           23..571
FT                   /note="Podocalyxin"
FT                   /id="PRO_5000095844"
FT   TOPO_DOM        23..474
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        475..495
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        496..571
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        257..348
FT                   /note="Pro-rich"
FT   MOD_RES         531
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R0M4"
FT   MOD_RES         550
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O00592"
FT   MOD_RES         569
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O00592"
FT   CARBOHYD        123
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        199
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:15814834,
FT                   ECO:0000269|PubMed:17332505"
FT   CARBOHYD        373
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:15814834,
FT                   ECO:0000269|PubMed:17332505"
FT   CARBOHYD        383
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:15814834,
FT                   ECO:0000269|PubMed:17332505"
FT   MUTAGEN         123
FT                   /note="N->Q: Does not reduce N-glycosylation."
FT                   /evidence="ECO:0000269|PubMed:15814834"
FT   MUTAGEN         199
FT                   /note="N->Q: Reduces N-glycosylation but not apical
FT                   targeting. Reduces strongly N-glycosylation but not apical
FT                   targeting; when associated with Q-373 and Q-383."
FT                   /evidence="ECO:0000269|PubMed:15814834,
FT                   ECO:0000269|PubMed:17332505"
FT   MUTAGEN         373
FT                   /note="N->Q: Reduces N-glycosylation but not apical
FT                   targeting. Reduces strongly N-glycosylation but not apical
FT                   targeting; when associated with Q-199 and Q-383."
FT                   /evidence="ECO:0000269|PubMed:15814834,
FT                   ECO:0000269|PubMed:17332505"
FT   MUTAGEN         383
FT                   /note="N->Q: Reduces N-glycosylation but not apical
FT                   targeting. Reduces strongly N-glycosylation but not apical
FT                   targeting; when associated with Q-199 and Q-373."
FT                   /evidence="ECO:0000269|PubMed:15814834,
FT                   ECO:0000269|PubMed:17332505"
SQ   SEQUENCE   571 AA;  59906 MW;  EA23F38263093539 CRC64;
     MRPAPPPPLL LLLLLLPPPS LSHDGTIIAA TSPTSGQPST ELPGGKGLIT TAKTIQNTDL
     AITGEKVMSA TVSKGPLPGS SNSVSMTLAP TQKNTVIAPD QDEKVSTNPT IATSDSKGIP
     DLNKSILPSA TNSMKPDTPV TQTAGPGAQG NPGTTVSHMT SENTEQTTSQ PPPQVKPSSI
     TPALTSIITP TSPRQPSANS TTLKPPESSS ESPDKSHTAS SSLGTKVVPS SSLYGTSPTR
     TSSVTFWGGP QSSSGTPPVP APTPRPAATS SSTPGISSVP GTTSLPSETE SLESPSSESP
     SQPPKLRPTG PPSSGSSGPA ASLPDEGPRS SSTQRAATAP RAPSVPSPTS AQGDDRIKCE
     SPGRLTDKML LLNLTRSGLC AGNNSDDKLI TLLCRAAKAT FNPAQDQCHI RLVPIQDTQA
     VAIKEITVQT NLLPRDVYEL LKDKWDELKE VGVSNMKLGD QGPPEETEDR FSMPLIITIV
     CMASFLLLVA ALYGCCHQRL SQRKDQQRLT EELQTVENGY HDNPTLEVME TSSEMQEKKV
     VNLNGELGDS WIVPLDNLAK DDLDEEEDTH L
//
